Bosutinib is a tyrosine kinase inhibitor that selectively targets BCR-ABL and Src family kinases, inhibiting abnormal cell proliferation. It is primarily used for the treatment of chronic myeloid leukemia (CML), especially in patients resistant or intolerant to prior therapies.

Bosutinib API is manufactured and supplied by ASTANDARDS | Artis Biotech, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.